Needham & Company LLC Lowers NeoGenomics (NASDAQ:NEO) Price Target to $18.00
NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by analysts at Needham & Company LLC from $19.00 to $18.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the medical research company’s stock. Needham & Company LLC’s price target would suggest a potential upside of 51.77% […]
NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by analysts at Needham & Company LLC from $19.00 to $18.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the medical research company’s stock. Needham & Company LLC’s price target would suggest a potential upside of 51.77% […]
